Narsimha Bogaraju

Title: Narsimha Bogaraju: Innovator in CNS Disorder Treatments

Introduction

Narsimha Bogaraju is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for the treatment of central nervous system (CNS) disorders. With a total of two patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Narsimha Bogaraju's latest patents include innovative compounds aimed at addressing CNS disorders. The first patent, titled "Substituted piperidines and piperazines and methods for the treatment of CNS disorders," focuses on heteroalicyclic compounds represented by a specific general formula. This invention also details methods for synthesizing these compounds, along with pharmaceutical compositions that utilize them for treating or preventing CNS-related disorders. The second patent, "Amide compounds as 5-HT4 receptor agonists," relates to compounds that are beneficial in treating various disorders associated with the 5-hydroxytryptamine 4 (5-HT) receptor. This patent also includes methods for creating these compounds and their pharmaceutical applications.

Career Highlights

Narsimha Bogaraju is currently associated with Suven Life Sciences Limited, a company known for its focus on drug discovery and development. His work at Suven Life Sciences has allowed him to contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Ramakrishna Nirogi and Anil Karbhari Shinde, who have collaborated with him on various projects within the company.

Conclusion

Narsimha Bogaraju's innovative work in developing compounds for CNS disorders showcases his dedication to advancing medical science. His patents reflect a commitment to improving treatment options for patients suffering from these conditions.